Aytu Biopharma, Inc. (AYTU)
2.14
+0.02
(+0.94%)
USD |
NASDAQ |
Sep 21, 16:00
2.14
0.00 (0.00%)
After-Hours: 20:00
Aytu Biopharma Total Assets (Quarterly) : 111.69M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 111.69M |
| December 31, 2025 | 122.00M |
| September 30, 2025 | 124.99M |
| June 30, 2025 | 124.43M |
| March 31, 2025 | 124.20M |
| December 31, 2024 | 116.23M |
| September 30, 2024 | 115.83M |
| June 30, 2024 | 118.86M |
| March 31, 2024 | 128.86M |
| December 31, 2023 | 131.25M |
| September 30, 2023 | 132.89M |
| June 30, 2023 | 137.84M |
| March 31, 2023 | 147.22M |
| December 31, 2022 | 141.44M |
| September 30, 2022 | 150.00M |
| June 30, 2022 | 137.62M |
| March 31, 2022 | 168.83M |
| December 31, 2021 | 223.82M |
| September 30, 2021 | 227.73M |
| June 30, 2021 | 276.58M |
| March 31, 2021 | 271.56M |
| December 31, 2020 | 166.74M |
| September 30, 2020 | 141.27M |
| June 30, 2020 | 155.10M |
| March 31, 2020 | 158.95M |
| Date | Value |
|---|---|
| December 31, 2019 | 74.48M |
| September 30, 2019 | 31.02M |
| June 30, 2019 | 34.72M |
| March 31, 2019 | 38.34M |
| December 31, 2018 | 42.40M |
| September 30, 2018 | 17.98M |
| June 30, 2018 | 21.06M |
| March 31, 2018 | 23.37M |
| December 31, 2017 | 18.86M |
| September 30, 2017 | 21.25M |
| June 30, 2017 | 15.00M |
| March 31, 2017 | 15.92M |
| December 31, 2016 | 21.51M |
| September 30, 2016 | 20.20M |
| June 30, 2016 | 24.34M |
| March 31, 2016 | 21.99M |
| December 31, 2015 | 24.41M |
| September 30, 2015 | 21.36M |
| June 30, 2015 | |
| March 31, 2015 | 10.20M |
| February 28, 2015 | 0.008M |
| November 30, 2014 | 0.0112M |
| August 31, 2014 | 0.0055M |
| May 31, 2014 | 0.0135M |
| February 28, 2014 | 0.0056M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 76.55M |
| Shareholders Equity (Quarterly) | 35.14M |
| Debt to Equity Ratio | 0.6527 |
| Current Ratio | 1.123 |
| Net Debt Paydown Yield | -3.96% |